Axtria® Makes Crain’s New York Business 2021 List Of Largest Privately-Held Companies

    Despite the global COVID-19 pandemic, Axtria’s continued fast growth in the past year has earned it a place on the Crain’s New York Business 2021 list of Largest Privately-Held Companies. The Crain’s New York Business annual list ranks companies by revenue earned.

    Compiled by Crain’s New York Business, the annual top privately held companies list is based on data reported by the companies and includes rankings estimated by Crain’s reporting staff using market statistics, background knowledge, and insider contacts.

    In 2021, Axtria secured a $150 million investment from Bain Capital (, initiated a plan to expand its workforce by 1,000 employees, and conducted employee-driven fundraising and medical support programs in the U.S. and India for COVID-19 victims.

    “We are greatly honored to be recognized by Crain’s New York Business for this milestone in the history of our company,” said Jassi Chadha, CEO & President of Axtria. “We look forward to expanding our organization in the region as a New-York area headquartered company - investing, building, and scaling our expertise in cutting-edge cloud and data analytics software technology.”

    More than ever, companies are looking to replace archaic and ad hoc systems with digital data enablement, analytics at scale, and omnichannel software to deliver improved customer experience. Serving this impending need, Axtria has emerged as a disruptive and innovative leader with a robust suite of AI-powered platforms - Axtria DataMAx™ for data management, Axtria InsightsMAx™ for analytics, and Axtria SalesIQ™ and Axtria CustomerIQ™ for omnichannel commercial operations.

    “The industry is not just looking for consultants and custom-built solutions but for partners that will help them bring therapeutic drugs to market faster and efficiently,” added Chadha. “Over the years, we have made significant investments in developing life sciences-focused software platforms that significantly improve strategic and day-to-day global operations.”

    Axtria supports more than 100 life sciences companies, including most of the top 20 global leaders with its cutting-edge software solutions. The company has been recognized for its growth in the Inc. 500, Deloitte Technology Fast 500™, NJBIZ Fast 50, SmartCEO Future 50, and Red Herring 100 rankings.

    Contact Information

    Neha Garg
    Axtria, Inc.

    About Axtria

    Axtria is a global provider of award-winning cloud software and data analytics to the life sciences industry. Axtria’s solutions are used to digitally transform the entire product commercialization process, supporting RWE/HEOR, medical affairs, pricing and market access, product launch and post-launch, and marketing and sales operations to drive growth and improve healthcare outcomes for patients. Our focus is on delivering solutions that help pharmaceutical, medical device, and diagnostics companies complete the journey from data to insights to action and get superior returns from their investments. As a participant of the United Nations Global Compact, Axtria is committed to aligning strategies and operations with universal principles on human rights, labor, environment, and anti-corruption and taking actions that advance societal goals. For more information, visit

    Connect with Axtria on: